德国的止痛药市场

Abstract

• Euromonitor International' s Analgesics in Germany report offers a comprehensive guide to the size and shape of the market at a national level.
• It provides the latest retail sales data (2002-2007), allowing you to identify the sectors driving growth.
• It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, distribution or pricing issues.
• Forecasts to 2012 illustrate how the market is set to change.
• Product coverage: adult analgesics, child-specific analgesics, systemic analgesics, topical analgesics
• Data coverage: market sizes (historic and forecasts), company shares, brand shares
• Why buy this report?
  • Get a detailed picture of the analgesics industry
  • Pinpoint growth sectors and trends and identify factors driving change
  • Understand the competitive environment, the market' s major players and leading brands
  • Use five-year forecasts to assess how the market is predicted to develop
• Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems.
• With offices in London, Chicago, Singapore Shanghai and Vilnius and a network of over 600 analysts worldwide, Euromonitor has a unique capability to develop reliable information resources to help drive informed strategic planning.

Table of Contents

• List of Contents and Tables
• OTC HEALTHCARE IN GERMANY
• Executive Summary
• Stagnating Sales
• Ageing Population Requires More Medical Care
• Distribution System Under Fire
• Market Concentration Continues
• Key Trends and Developments
• German Consumers: Older, But Working Longer and Playing Harder
• German Consumers Ever More Health Aware
• German Distribution System Shake Up
• Rx-to-otc Switches
• Market Concentration Continues
• Market Indicators
  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2002-2007
  • Table 2 Life Expectancy at Birth 2002-2007
• Market Data
  • Table 3 Sales of OTC Healthcare by Sector: Value 2002-2007
  • Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2002-2007
  • Table 5 OTC Healthcare Company Shares by Value 2003-2007
  • Table 6 OTC Healthcare Brand Shares by Value 2004-2007
  • Table 7 Penetration of Private Label by Sector 2003-2007
  • Table 8 Sales of OTC Healthcare by Distribution Format: % Analysis 2002-2007
  • Table 9 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2007
  • Table 10 Forecast Sales of OTC Healthcare by Sector: Value 2007-2012
  • Table 11 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2007-2012
• Appendix
• OTC Registration and Classification
• Vitamins and Dietary Supplements Registration and Classification
• Generics
• Consumer Expenditure on Health Goods and Medical Services
• Definitions
• Sources
  • Summary 1 Research Sources
• LOCAL COMPANY PROFILES - GERMANY
• Bayer Healthcare AG
• Strategic Direction
• Key Facts
  • Summary 2 Bayer HealthCare AG: Key Facts
  • Summary 3 Bayer HealthCare AG: Operational Indicators (Global)
• Company Background
• Production
• Competitive Positioning
  • Summary 4 Bayer Healthcare AG: Competitive Position 2007
• Beiersdorf AG
• Strategic Direction
• Key Facts
  • Summary 5 Beiersdorf AG: Key Facts
  • Summary 6 Beiersdorf AG: Operational Indicators (Global)
• Company Background
• Production
• Competitive Positioning
  • Summary 7 Beiersdorf AG: Competitive Position 2007
• Boehringer Ingelheim Pharma GmbH & Co Kg
• Strategic Direction
• Key Facts
  • Summary 8 Boehringer Ingelheim Pharma GmbH & Co KG: Key Facts
  • Summary 9 Boehringer Ingelheim Pharma GmbH & Co KG: Operational Indicators (Global)
• Company Background
• Production
• Competitive Positioning
  • Summary 10 Boehringer Ingelheim Pharma GmbH & Co KG: Competitive Position 2007
• Johnson & Johnson GmbH
• Strategic Direction
• Key Facts
  • Summary 11 Johnson & Johnson GmbH: Key Facts
  • Summary 12 Johnson & Johnson GmbH: Operational Indicators (Global)
• Company Background
• Production
• Competitive Positioning
  • Summary 13 Johnson & Johnson GmbH: Competitive Position 2007
• Mcm Klosterfrau Vertriebsgesellschaft Mbh
• Strategic Direction
• Key Facts
  • Summary 14 MCM Klosterfrau Vertriebsgesellschaft mbH: Key Facts
• Company Background
• Production
• Competitive Positioning
  • Summary 15 MCM Klosterfrau Vertriebsgesellschaft mbH: Competitive Position 2007
• Novartis Deutschland GmbH
• Strategic Direction
• Key Facts
  • Summary 16 Novartis Deutschland GmbH: Key Facts
  • Summary 17 Novartis Deutschland GmbH: Operational Indicators (Global)
• Company Background
• Production
• Competitive Positioning
  • Summary 18 Novartis Consumer Health GmbH: Competitive Position 2007
• Ratiopharm GmbH & Co
• Strategic Direction
• Key Facts
  • Summary 19 Ratiopharm GmbH & Co: Key Facts
  • Summary 20 Ratiopharm GmbH & Co: Operational Indicators (Global)
• Company Background
• Production
• Competitive Positioning
  • Summary 21 Ratiopharm GmbH & Co: Competitive Position 2007
• Stada Arzneimittel AG
• Strategic Direction
• Key Facts
  • Summary 22 STADA Arzneimittel AG: Key Facts
  • Summary 23 STADA Arzneimittel AG: Operational Indicators (Global)
• Company Background
• Production
• Competitive Positioning
  • Summary 24 STADA Arzneimittel AG: Competitive Position 2007
• ANALGESICS IN GERMANY
• Headlines
• Trends
• Switches
• Competitive Landscape
• Prospects
• Sector Data
  • Table 12 Sales of Analgesics by Subsector: Value 2002-2007
  • Table 13 Sales of Analgesics by Subsector: % Value Growth 2002-2007
  • Table 14 Herbal vs Standard Topical Analgesics 2002-2007
  • Table 15 Topical Analgesics by Format: % Value Breakdown 2004-2007
  • Table 16 Analgesics Company Shares by Value 2003-2007
  • Table 17 Analgesics Brand Shares by Value 2004-2007
  • Table 18 Forecast Sales of Analgesics by Subsector: Value 2007-2012
  • Table 19 Forecast Sales of Analgesics by Subsector: % Value Growth 2007-2012
• Analgesics Germany